ImmunoCellular Therapeutics Ltd Company Profile (NYSEMKT:IMUC)

About ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)

ImmunoCellular Therapeutics Ltd logoImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is developing immune-based therapies for the treatment of cancers. The Company's cancer immunotherapies target cancer stem cells (CSCs), which are the drivers of tumor growth and disease recurrence. Its product candidate is ICT-107, which is in phase III testing. In addition, the Company also has a portfolio of other potential therapeutic immunotherapies using a range of approaches to treat cancer. Its other product candidates are ICT-140 and ICT-121. ICT-107 is a dendritic cell (DC) vaccine for the treatment of newly diagnosed glioblastoma multiforme (GBM), a type of brain cancer. ICT-140 is a DC vaccine that targets over seven tumor-associated antigens expressed on ovarian cancer cells. It is developing ICT-121, a dendritic cell (DC)-based vaccine targeting CD133+ CSCs for the treatment of recurrent GBM and other solid tumor cancers, including ovarian, pancreatic and breast cancers.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology & Medical Research - NEC
  • Sub-Industry: Biotechnology
  • Symbol: NYSEMKT:IMUC
  • CUSIP: 45253610
  • Web: imuc.com/
Average Prices:
  • 50 Day Moving Avg: $0.94
  • 200 Day Moving Avg: $1.98
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.0000
Profitability:
  • Return on Equity: -706.88%
  • Return on Assets: -170.56%
 
Frequently Asked Questions for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)

What is ImmunoCellular Therapeutics Ltd's stock symbol?

ImmunoCellular Therapeutics Ltd trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "IMUC."

How were ImmunoCellular Therapeutics Ltd's earnings last quarter?

ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) announced its quarterly earnings results on Monday, August, 22nd. The company reported ($0.06) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.07) by $0.01. View ImmunoCellular Therapeutics Ltd's Earnings History.

Where is ImmunoCellular Therapeutics Ltd's stock going? Where will ImmunoCellular Therapeutics Ltd's stock price be in 2017?

1 brokers have issued 1 year target prices for ImmunoCellular Therapeutics Ltd's stock. Their forecasts range from $2.00 to $2.00. On average, they expect ImmunoCellular Therapeutics Ltd's share price to reach $2.00 in the next twelve months. View Analyst Ratings for ImmunoCellular Therapeutics Ltd.

Who are some of ImmunoCellular Therapeutics Ltd's key competitors?

Who are ImmunoCellular Therapeutics Ltd's key executives?

ImmunoCellular Therapeutics Ltd's management team includes the folowing people:

  • Anthony J. Gringeri Ph.D., President, Chief Executive Officer, Director
  • David E. Fractor, Chief Financial Officer
  • Rahul Singhvi, Lead Independent Director
  • John S. Yu M.D., Director
  • Anthony Gregg Lapointe, Independent Director
  • Mark A. Schlossberg Esq., Independent Director
  • Gary S. Titus, Independent Director

How do I buy ImmunoCellular Therapeutics Ltd stock?

Shares of ImmunoCellular Therapeutics Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.


MarketBeat Community Rating for ImmunoCellular Therapeutics Ltd (NYSEMKT IMUC)
Community Ranking:  2.7 out of 5 ( )
Outperform Votes:  82 (Vote Outperform)
Underperform Votes:  68 (Vote Underperform)
Total Votes:  150
MarketBeat's community ratings are surveys of what our community members think about ImmunoCellular Therapeutics Ltd and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.00

Analysts' Ratings History for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Show:
DateFirmActionRatingPrice TargetDetails
11/11/2016Maxim GroupDowngradeBuy -> HoldView Rating Details
11/12/2015Roth CapitalReiterated RatingBuy$3.00View Rating Details
(Data available from 7/27/2015 forward)

Earnings

Earnings History for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Earnings by Quarter for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Earnings History by Quarter for ImmunoCellular Therapeutics Ltd (NYSEMKT IMUC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016Q316($0.04)($0.04)ViewN/AView Earnings Details
8/22/2016Q2($0.07)($0.06)ViewListenView Earnings Details
5/12/2016Q116($0.07)($0.06)ViewListenView Earnings Details
3/30/2016Q415($0.06)($0.05)ViewListenView Earnings Details
11/10/2015Q315($0.06)($0.04)ViewN/AView Earnings Details
8/6/2015Q215($0.05)($0.03)ViewN/AView Earnings Details
5/11/2015Q1($0.02)($0.02)ViewN/AView Earnings Details
3/9/2015Q414($0.05)($0.04)ViewN/AView Earnings Details
11/10/2014Q314($0.06)($0.03)ViewN/AView Earnings Details
8/11/2014($0.06)($0.04)ViewN/AView Earnings Details
5/9/2014Q114($0.04)($0.05)ViewN/AView Earnings Details
5/9/2013Q1 2013($0.08)($0.05)ViewN/AView Earnings Details
3/5/2013Q4 2012($0.08)$0.01ViewN/AView Earnings Details
11/12/2012Q312($0.02)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Insider Trades by Quarter for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Institutional Ownership by Quarter for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Insider Trades by Quarter for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/30/2015Andrew GengosCEOBuy10,000$0.44$4,400.00View SEC Filing  
2/18/2015Andrew GengosCEOBuy41,333$0.60$24,799.80View SEC Filing  
2/18/2015Andrew GengosCEOBuy41,333$0.60$24,799.80View SEC Filing  
2/18/2015Anthony GringeriVPBuy30,000$0.60$18,000.00View SEC Filing  
2/18/2015David FractorVPBuy16,667$0.60$10,000.20View SEC Filing  
8/21/2014Anthony GringeriVPBuy11,000$0.91$10,010.00View SEC Filing  
8/14/2014Andrew GengosCEOBuy10,000$0.90$9,000.00View SEC Filing  
12/20/2013Gary TitusDirectorBuy18,000$0.78$14,040.00View SEC Filing  
12/18/2013Andrew GengosCEOBuy27,000$0.72$19,440.00View SEC Filing  
10/21/2013John S YuInsiderSell267,387$2.91$778,096.17View SEC Filing  
8/29/2013James BenderVPSell14,203$2.87$40,762.61View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Latest Headlines for ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Source:
DateHeadline
seekingalpha.com logoImmunocellular prices equity offering; shares down 48% - Seeking Alpha
seekingalpha.com - July 18 at 10:28 PM
247wallst.com logoAT&T, Harley-Davidson Skid into Tuesday’s 52-Week Low Club
247wallst.com - July 18 at 10:25 PM
streetinsider.com logoImmunoCellular Therapeutics (IMUC) Prices Offering of Convertible Preferred Stock and Warrants
www.streetinsider.com - July 18 at 10:25 PM
finance.yahoo.com logoImmunoCellular Therapeutics Announces Pricing of Public Offering of Convertible Preferred Stock and Warrants
finance.yahoo.com - July 18 at 10:25 PM
finance.yahoo.com logoDEADLINE TODAY: Levi & Korsinsky, LLP Reminds ImmunoCellular Therapeutics, Ltd. Shareholders of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 - IMUC
finance.yahoo.com - June 30 at 7:57 PM
streetinsider.com logoImmunoCellular Therapeutics (IMUC) Receives Notice from NYSE ... - StreetInsider.com
www.streetinsider.com - June 30 at 12:13 AM
finance.yahoo.com logoDEADLINE TOMORROW: The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of ImmunoCellular Therapeutics, Ltd. Shareholders and a Lead Plaintiff Deadline of June 30, 2017
finance.yahoo.com - June 30 at 12:10 AM
finance.yahoo.com logoACT NOW - DEADLINE TOMORROW: Monteverde & Associates PC Reminds Investors of a Class Action Filed on Behalf of ImmunoCellular Therapeutics, Ltd. Shareholders and a Lead Plaintiff Deadline of June 30, 2017 - IMUC
finance.yahoo.com - June 30 at 12:10 AM
finance.yahoo.com logoDEADLINE TOMORROW: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - June 30 at 12:10 AM
finance.yahoo.com logoImmunoCellular Therapeutics Receives Notice from NYSE MKT for Noncompliance with Continued Listing Standards
finance.yahoo.com - June 30 at 12:10 AM
bizjournals.com logoIMUC ALERT: Rosen Law Firm Reminds ImmunoCellular Therapeutics, Ltd. Investors of Important June 30 Deadline in Class Action - IMUC
www.bizjournals.com - June 28 at 7:22 PM
prnewswire.com logoJUNE 30 DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular ... - PR Newswire (press release)
www.prnewswire.com - June 28 at 7:22 PM
prnewswire.com logoIMUC ALERT: Rosen Law Firm Reminds ImmunoCellular Therapeutics, Ltd. Investors of Important June 30 Deadline in ... - PR Newswire (press release)
www.prnewswire.com - June 28 at 7:22 PM
finance.yahoo.com logoDEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors with Over $500k in Losses of Class Action Against ImmunoCellular Therapeutics, Ltd. (IMUC) and Lead Plaintiff Deadline - June 30, 2017
finance.yahoo.com - June 28 at 7:22 PM
finance.yahoo.com logoUPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving ImmunoCellular Therapeutics, Ltd. and a Lead Plaintiff Deadline of June 30, 2017
finance.yahoo.com - June 28 at 7:22 PM
finance.yahoo.com logoJUNE 30 DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - June 28 at 7:22 PM
globenewswire.com logoFRIDAY JUNE 30 DEADLINE: Khang & Khang LLP Announces a ... - GlobeNewswire (press release)
globenewswire.com - June 27 at 11:07 PM
finance.yahoo.com logoFRIDAY DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - June 26 at 7:43 PM
finance.yahoo.com logoONE WEEK DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - June 24 at 4:17 AM
globenewswire.com logoEQUITY ALERT: Levi & Korsinsky, LLP Reminds ImmunoCellular Therapeutics, Ltd. Shareholders of a Class Action ... - GlobeNewswire (press release)
globenewswire.com - June 23 at 6:10 PM
finance.yahoo.com logoEQUITY ALERT: Levi & Korsinsky, LLP Reminds ImmunoCellular Therapeutics, Ltd. Shareholders of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 – IMUC
finance.yahoo.com - June 23 at 6:10 PM
prnewswire.com logoImmunoCellular Therapeutics Provides Update on Strategic Review and Decision to Suspend Further Patient ... - PR Newswire (press release)
www.prnewswire.com - June 22 at 6:14 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds ImmunoCellular Therapeutics, Ltd. Shareholders of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 - IMUC
finance.yahoo.com - June 22 at 1:12 PM
finance.yahoo.com logoDEADLINE APPROACHING: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - June 22 at 1:12 PM
streetinsider.com logoImmunoCellular Therapeutics (IMUC) Updates Strategic Review & Decision to Suspend Further Patient Randomization ... - StreetInsider.com
www.streetinsider.com - June 21 at 3:36 PM
finance.yahoo.com logoImmunoCellular Therapeutics Provides Update on Strategic Review and Decision to Suspend Further Patient Randomization for ICT-107 Phase 3 Trial
finance.yahoo.com - June 21 at 3:36 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds ImmunoCellular Therapeutics, Ltd. Shareholders of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 - IMUC
finance.yahoo.com - June 21 at 3:36 PM
finance.yahoo.com logo9-DAY DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - June 21 at 3:36 PM
finance.yahoo.com logoIMUC INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - June 20 at 6:47 PM
finance.yahoo.com logoUPCOMING DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - June 19 at 4:53 PM
finance.yahoo.com logoUPCOMING DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - June 17 at 4:51 AM
finance.yahoo.com logoEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of ImmunoCellular Therapeutics, Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 - IMUC
finance.yahoo.com - June 15 at 8:19 PM
finance.yahoo.com logoLaw Offices of Howard G. Smith Reminds ImmunoCellular Therapeutics, Ltd. Investors of Pending Lawsuit and Upcoming Lead Plaintiff Deadline
finance.yahoo.com - June 15 at 8:19 PM
finance.yahoo.com logoSHAREHOLDER REMINDER: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - June 15 at 8:19 PM
prnewswire.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities ... - PR Newswire (press release)
www.prnewswire.com - June 14 at 7:50 PM
finance.yahoo.com logoDEADLINE APPROACHING: Monteverde & Associates PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd - IMUC & Reminds Investors of June 30th, 2017 Lead Plaintiff Deadline
finance.yahoo.com - June 14 at 7:50 PM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. - IMUC
finance.yahoo.com - June 14 at 7:50 PM
finance.yahoo.com logoSHAREHOLDER REMINDER: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - June 14 at 7:50 PM
finance.yahoo.com logoJune 30 Deadline Alert: GPM Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd.
finance.yahoo.com - June 14 at 11:20 AM
finance.yahoo.com logoDEADLINE APPROACHING: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - June 13 at 5:42 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of ImmunoCellular Therapeutics, Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 - IMUC
finance.yahoo.com - June 12 at 6:29 PM
finance.yahoo.com logoImmunoCellular Therapeutics to Present at Marcum MicroCap Conference on June 15, 2017
finance.yahoo.com - June 12 at 6:29 PM
finance.yahoo.com logoAPPROACHING DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - June 12 at 6:29 PM
finance.yahoo.com logoEQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - June 10 at 1:22 AM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ImmunoCellular Therapeutics, Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 - IMUC
finance.yahoo.com - June 7 at 5:29 PM
finance.yahoo.com logoEQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - June 7 at 5:29 PM
finance.yahoo.com logoThe Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of ImmunoCellular Therapeutics, Ltd. Shareholders and a Lead Plaintiff Deadline of June 30, 2017
finance.yahoo.com - June 6 at 6:25 PM
finance.yahoo.com logoINVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against ImmunoCellular Therapeutics, Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - June 6 at 6:25 PM
streetinsider.com logoImmunoCellular Therapeutics (IMUC) Presents Data from ICT-121 Phase 1 Trial in Recurrent Glioblastoma at ASCO ... - StreetInsider.com
www.streetinsider.com - June 5 at 10:57 PM
streetinsider.com logoImmunoCellular Therapeutics (IMUC) Presents Data from ICT-121 Phase 1 Trial in Recurrent Glioblastoma at ASCO Meetings
www.streetinsider.com - June 5 at 10:57 PM

Social

This page was last updated on 7/27/2017 by MarketBeat.com Staff